In the VDS Gold Rush, Tomson Biotech Reshapes Market with Scientific Innovation

As the pursuit of a healthy lifestyle continues to gain momentum, the dietary supplement (VDS) industry has entered a golden period of rapid development. At the beginning of this year, statistics released by the Economic Reference Daily showed that in January 2024 alone, the number of newly registered enterprises related to dietary nutrition food in China reached over 132,000, a 122.6% increase compared to the same period last year.

In this crowded racetrack filled with "gold diggers," both market order and value order have been severely impacted. On group buying platforms, there are white-label products claiming factory direct sales to initiate group purchases; in live broadcast rooms, there are OEM products that can be purchased at ultra-low prices; there are also many international brands that have crossed borders and internet-famous brands that have seen explosive sales in a short period of time...

As a leading global enterprise in the dietary supplement industry, BY-HEALTH has not blindly chased traffic but has taken a different path. Relying on its continuous investment and profound accumulation in scientific and technological innovation, BY-HEALTH has reshaped the market structure and is doing its utmost to lead the industry towards higher quality and more scientific development.

Today's consumers are becoming more rational, and it is difficult to win trust for a long time with only marketing and low prices. The quality-price ratio, ingredient list, relevant scientific evidence, and functional segmentation demands are the focuses of consumers. Scientific evidence of product efficacy has become an important basis for consumer choice and also determines the core competitiveness of enterprises.

Advertisement

Therefore, BY-HEALTH has always regarded scientific research and innovation as the core strategy for development, relying on its strong technology center and profound R&D strength to continuously promote product upgrades and technological innovation. In recent years, BY-HEALTH has achieved significant results in product research and development, technological innovation, and international cooperation, bringing more high-quality and scientifically effective dietary supplement products to consumers.

For example, BY-HEALTH has been working for 8 years on in-depth research on light络素, known as "natural aspirin," to maintain normal platelet aggregation function. It has completed the experimental verification of the impact of BY-HEALTH's new络素 tablets on the blood flow health of Chinese people, filling a domestic gap and appearing on several international authoritative scientific magazines. BY-HEALTH has become the first enterprise in the industry to submit a new function declaration and product registration application.

To accelerate the pace of scientific and technological innovation, BY-HEALTH actively cooperates with well-known domestic and foreign scientific research institutions and global high-quality raw material suppliers to jointly build a "collaborative innovation R&D cooperation platform." Through cooperation with top institutions such as the Shanghai Nutrition and Health Research Institute of the Chinese Academy of Sciences, BASF, Fonterra, and DuPont Nutrition & Biosciences, BY-HEALTH has made important breakthroughs in the fields of anti-aging and nutritional intervention.

For example, the discovery of PCC1 by global authoritative scientific research institutions can efficiently and safely remove senescent cells, becoming a "new milestone in combating aging." This discovery marks an important step for BY-HEALTH in the field of anti-aging research. If products in this direction are launched, they will also bring ample room for imagination.

Moreover, BY-HEALTH has established the "BY-HEALTH Nutrition and Health Research Fund," mainly used to support scientific research projects, fund the research and innovation of dietary supplements, and practical application research, and carry out industry-university-research project cooperation. Since its establishment in 2012, the fund has been operating for 9 years, supporting dozens of scientific research projects and carrying out extensive scientific research cooperation with many domestic and foreign universities, research institutes, and tertiary hospitals. These cooperations have not only brought rich scientific research achievements to BY-HEALTH but also provided important support for the innovative development of the entire industry.

This series of arrangements for scientific research innovation and product upgrades have made BY-HEALTH popular among consumers and stand out in the fierce competition of the VDS industry. At the beginning of August this year, BY-HEALTH released the semi-annual report for the first half of 2024. The report shows that in the continuously heating gold rush, BY-HEALTH achieved a business income of 4.613 billion yuan, and the net profit attributable to the shareholders of the listed company was 891 million yuan. Although the performance has fluctuated, it still holds a leading position in the industry.In response to the skepticism of "focusing on marketing while neglecting research and development," By-Health has consistently demonstrated its commitment to scientific research over the decades, and has answered with its long-standing leading position and fruitful achievements. In the race of dietary nutritional supplements, it has never been a competition for traffic, but a competition to wholeheartedly produce higher quality and more scientifically powerful products for consumers. As By-Health's Chairman Liang Yunchao once emphasized: "The industry on the tip of the tongue, the enterprise on the edge of the knife. VDS is an industry on the very tip of the knife, always walking on thin ice, always cautious, always with a heart full of awe, and never daring to be the slightest bit negligent. One must measure with their own values and conscience, and with the empathy of 'family and friends'."